$ALGS Cashflow Statement | Understand Stock

$ALGS

$4.65 -$0.13 (2.72%) Close

$ALGS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discount on investments
Non cash lease expense
Impairment of right of use assets
Change in fair value of 2023 Common Warrants
Loss on disposal of assets
Depreciation expense
Stock-based compensation including ESPP
Changes in operating assets and liabilities:
Right of use assets
Accounts payable
Accrued liabilities
Operating lease liabilities
Other liabilities
Deferred revenue
Deferred revenue from customers
Other assets

Net cash and cash equivalents used in operating activities
Cash flows from investing activities:
Maturities of short-term investments
Purchase of short-term investments
Purchases of long-term investments
Purchases of property and equipment
Net cash and cash equivalents used in investing activities

Cash flows from financing activities:
Proceeds from issuance of common stock in connection with PIPE Offering, net of costs
Proceeds from issuance of pre-funded warrants in connection with PIPE Offering, net of costs
Proceeds from issuance of common warrants in connection with PIPE Offering, net of costs
Proceeds from issuance of common stock upon exercise of pre-funded warrants
Proceeds from issuance of common stock, common warrants and pre-funded warrants in connection with PIPE offering, net of costs
Payments on finance lease
Payments of deferred offering costs
Proceeds from the ESPP purchase
Proceeds from the exercise of common stock option
Follow-on Offering
Employee Stock
Total proceeds from the exercise of common stock option

Net cash and cash equivalents provided by financing activities

Net decrease in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
Cash and cash equivalents
Restricted cash
Supplemental disclosures of cash flow information:
Supplemental disclosures of noncash financing and investing activities:
Mark to market adjustment for available-for-sale investments
Receviable due from arrangement
Equipment acquired through finance lease
Acquisition of right of use asset through operating lease obligation
Vesting of early exercised options
PP&E Purchase still in Accounts Payable
Change in pension obligation
Net exercise of common warrants

Comments